|
|
News for Healthier Living
Updated Review Shows GLP-1 RAs Produce Significant Weight Loss in Adults Without Diabetes, with Newer Treatments Showing Greater Results
An updated systematic review evaluating the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and coagonists among adults with overweight or obesity without diabetes found that among currently available treatments, tirzepatide produced the greatest weight loss, while newer experimental drugs showed even larger effects.
August 31, 2026
September 1 2026August 31 2026August 30 2026August 29 2026August 28 2026August 27 2026August 26 2026August 25 2026August 24 2026August 21 2026August 20 2026August 19 2026August 18 2026
|
|
|
|
|